Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,currency,epsCurrentYear,market,shortName,exchange,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,exchangeDataDelayedBy,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Apr 14, 2021) 4","Short Ratio (Apr 14, 2021) 4","Short % of Float (Apr 14, 2021) 4","Short % of Shares Outstanding (Apr 14, 2021) 4","Shares Short (prior month Mar 14, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,ESTA,70348000.0,23686000,4466000,,-6146000,,-5644000,18195000,14644000,-8017000,-8017000,,-2211000,,,,-502000,26963000,34980000,12319000,1871000,,-5644000,-5644000,4148000.0,26717000.0,81427000.0,74961000.0,1883000.0,156388000.0,213471000.0,2632000.0,-165246000.0,3772000.0,465000.0,19000.0,664000.0,84523000.0,25900000.0,2873000.0,18812000.0,132299000.0,19127000.0,49832000.0,23374000.0,9722000.0,2357000,-1124000,-53000,538000,1389000,680000,3092000,-89000,244000,3434000,1209000,6508000,514000,-3357000,-287000,106399000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,74.5,1630510176,-0.5,74.99,74.99,73.885,13585,-63.675217,3.187,72.87222,1.6277771,0.022337414,71.95457,2.545433,0.035375558,1764606976,-79.25532,23.376215,15,America/New_York,EDT,False,False,USD,-1.17,us_market,Establishment Labs Holdings Inc,NCM,REGULAR,2,-0.6666667,73.885 - 74.99,75.0,73.9,74.32,9,10,finmb_417932316,NasdaqCM,Establishment Labs Holdings Inc.,USD,105460,101666,58.0,3.5151515,16.5 - 88.66,-14.160004,-0.15971129,16.5,88.66,1620217800,1620217800,0,1620217800,-1.635,-0.94,-14400000,1.07,,,88.66,16.5,72.87,71.95,105.46k,101.67k,23.69M,,13.18M,10.60%,57.82%,152.8k,1.54,0.83%,0.65%,154.78k,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",-45.02%,-32.97%,-12.79%,-66.54%,84.68M,3.63,11.20%,52.5M,-24.57M,-38.12M,-1.63,,84.52M,3.59,52.7M,70.31,5.11,3.19,-12.51M,-5.37M,Value,Healthcare,521,"Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.",Alajuela,506 2434 2400,1609372800,Costa Rica,http://www.establishmentlabs.com,86400,Building B15 and 25,Medical Devices,Coyol Free Zone
t-1,ESTA,75955000.0,23686000,2729000,,-4066000,,-4247000,15008000,15146000,-2591000,-2591000,,-2886000,,,,181000,22758000,25349000,7612000,-1475000,,-4247000,-4247000,3537000.0,25658000.0,74727000.0,79957000.0,1370000.0,154684000.0,212752000.0,,-159602000.0,5024000.0,465000.0,1149000.0,401000.0,81431000.0,20141000.0,4003000.0,16263000.0,134018000.0,18756000.0,49374000.0,28400000.0,6954000.0,-1978000,-2153000,-85000,90000,583000,192000,-4951000,-17000,159000,-3047000,873000,1513000,-859000,633000,-2001000,113877000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,74.5,1630510176,-0.5,74.99,74.99,73.885,13585,-63.675217,3.187,72.87222,1.6277771,0.022337414,71.95457,2.545433,0.035375558,1764606976,-79.25532,23.376215,15,America/New_York,EDT,False,False,USD,-1.17,us_market,Establishment Labs Holdings Inc,NCM,REGULAR,2,-0.6666667,73.885 - 74.99,75.0,73.9,74.32,9,10,finmb_417932316,NasdaqCM,Establishment Labs Holdings Inc.,USD,105460,101666,58.0,3.5151515,16.5 - 88.66,-14.160004,-0.15971129,16.5,88.66,1620217800,1620217800,0,1620217800,-1.635,-0.94,-14400000,1.07,,,88.66,16.5,72.87,71.95,105.46k,101.67k,23.69M,,13.18M,10.60%,57.82%,152.8k,1.54,0.83%,0.65%,154.78k,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",-45.02%,-32.97%,-12.79%,-66.54%,84.68M,3.63,11.20%,52.5M,-24.57M,-38.12M,-1.63,,84.52M,3.59,52.7M,70.31,5.11,3.19,-12.51M,-5.37M,Value,Healthcare,521,"Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.",Alajuela,506 2434 2400,1609372800,Costa Rica,http://www.establishmentlabs.com,86400,Building B15 and 25,Medical Devices,Coyol Free Zone
t-2,ESTA,77841000.0,23686000,2399000,,-10277000,,-10471000,14438000,7234000,-9603000,-9603000,,-2130000,,,,194000,10474000,20077000,3240000,-674000,,-10471000,-10471000,3480000.0,24338000.0,75026000.0,81786000.0,2006000.0,156812000.0,211932000.0,,-155355000.0,5327000.0,465000.0,871000.0,360000.0,86382000.0,20552000.0,3725000.0,16085000.0,136422000.0,17142000.0,48939000.0,29057000.0,8293000.0,-1655000,-1333000,-63000,116000,3262000,193000,-7214000,-14000,98000,-6095000,796000,-3673000,4321000,916000,-1100000,115870000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,74.5,1630510176,-0.5,74.99,74.99,73.885,13585,-63.675217,3.187,72.87222,1.6277771,0.022337414,71.95457,2.545433,0.035375558,1764606976,-79.25532,23.376215,15,America/New_York,EDT,False,False,USD,-1.17,us_market,Establishment Labs Holdings Inc,NCM,REGULAR,2,-0.6666667,73.885 - 74.99,75.0,73.9,74.32,9,10,finmb_417932316,NasdaqCM,Establishment Labs Holdings Inc.,USD,105460,101666,58.0,3.5151515,16.5 - 88.66,-14.160004,-0.15971129,16.5,88.66,1620217800,1620217800,0,1620217800,-1.635,-0.94,-14400000,1.07,,,88.66,16.5,72.87,71.95,105.46k,101.67k,23.69M,,13.18M,10.60%,57.82%,152.8k,1.54,0.83%,0.65%,154.78k,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",-45.02%,-32.97%,-12.79%,-66.54%,84.68M,3.63,11.20%,52.5M,-24.57M,-38.12M,-1.63,,84.52M,3.59,52.7M,70.31,5.11,3.19,-12.51M,-5.37M,Value,Healthcare,521,"Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.",Alajuela,506 2434 2400,1609372800,Costa Rica,http://www.establishmentlabs.com,86400,Building B15 and 25,Medical Devices,Coyol Free Zone
t-3,ESTA,86377000.0,23686000,4199000,,-17528000,,-17759000,18984000,15478000,-7705000,-7705000,,-2146000,,,,231000,24481000,32186000,9003000,-9823000,,-17759000,-17759000,3465000.0,22799000.0,78116000.0,90307000.0,2350000.0,168423000.0,211734000.0,,-144884000.0,6921000.0,465000.0,658000.0,362000.0,93596000.0,22460000.0,3512000.0,16235000.0,147896000.0,21615000.0,48529000.0,25512000.0,9881000.0,366000,-949000,-76000,63926000,-601000,64036000,55941000,-34000,-234000,-6802000,833000,438000,-171000,9704000,-687000,125436000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,74.5,1630510176,-0.5,74.99,74.99,73.885,13585,-63.675217,3.187,72.87222,1.6277771,0.022337414,71.95457,2.545433,0.035375558,1764606976,-79.25532,23.376215,15,America/New_York,EDT,False,False,USD,-1.17,us_market,Establishment Labs Holdings Inc,NCM,REGULAR,2,-0.6666667,73.885 - 74.99,75.0,73.9,74.32,9,10,finmb_417932316,NasdaqCM,Establishment Labs Holdings Inc.,USD,105460,101666,58.0,3.5151515,16.5 - 88.66,-14.160004,-0.15971129,16.5,88.66,1620217800,1620217800,0,1620217800,-1.635,-0.94,-14400000,1.07,,,88.66,16.5,72.87,71.95,105.46k,101.67k,23.69M,,13.18M,10.60%,57.82%,152.8k,1.54,0.83%,0.65%,154.78k,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",-45.02%,-32.97%,-12.79%,-66.54%,84.68M,3.63,11.20%,52.5M,-24.57M,-38.12M,-1.63,,84.52M,3.59,52.7M,70.31,5.11,3.19,-12.51M,-5.37M,Value,Healthcare,521,"Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.",Alajuela,506 2434 2400,1609372800,Costa Rica,http://www.establishmentlabs.com,86400,Building B15 and 25,Medical Devices,Coyol Free Zone
